baber/WOPTO huggingface dataset:
Patent CA-2453127-A1 (CA)
Title: Method and system for correlating and determining root causes of system and enterprise events
Inventor: CONNELLY KIERON
IPC: G06F11/34
Filed: 2002-07-08
Abstract: A method, system, GUI, API, computer readable media, and data structures for simplifying managing a complex system of enterprise components is provided.  The computer executable methodology includes correlating and determining root causes of enterprise events. Enterprise component management is therefore simplified by automatically distinguishing symptomatic events from root cause events, which facilitates taking appropriate maintenance actions in a timely fashion. The system provides a computer-based system for receiving and correlating events and then diagnosing a root cause event from a time related set of such received, correlated events. The system includes computer components for receiving, storing and correlating events and a root cause determiner for analyzing such events and related correlation rules.
Patent CA-2453581-A1 (CA)
Inventor: ANDREWS PETER S
IPC: H01L33/62
Filed: 2002-07-23
Abstract: Light emitting diodes include a substrate, an epitaxial region on the substrate that includes therein a diode region and a multilayer conductive stack on the epitaxial region opposite the substrate. A passivation layer extends at least partially on the multilayer conductive stack opposite the epitaxial region, to define a bonding region on the multilayer conductive stack opposite the epitaxial region. The passivation layer also extends acro ss the multilayer conductive stack, across the epitaxial region and onto the substrate. The multilayer conductive stack can include an ohmic layer on the epitaxial region opposite the substrate, a reflector layer on the ohmic laye r opposite the epitaxial region and a tin barrier layer on the reflector layer opposite the ohmic layer. An adhesion layer also may be provided on the tin barrier layer opposite the reflector layer. A bonding layer also may be provided on the adhesion layer opposite the tin barrier layer. A submount an d a bond between the bonding layer and the submount also may be provided.</SDO AB>
Patent CA-2454552-A1 (CA)
Inventor: SCHWARZ JOHANNES
IPC: A61L27/00
Filed: 2002-07-19
Abstract: L'invention concerne un procédé de culture de populations cellulaires comportant une pluralité de cellules. Ce procédé comprend une ou plusieurs étapes parmi lesquelles figurent l'expansion et la modification des cellules de la population cellulaire dans un milieu de culture. L'objectif de l'invention est de développer un procédé de culture cellulaire plus rapide et plus homogène par rapport au nombre de cellules présentes dans le milieu de culture. A cet effet, l'on utilise une population cellulaire dont les cellules sont présentes en grande partie sous la forme de cellules isolées et/ou d'agglomérats de cellules présentant de faibles interactions cellulaires lors du procédé de culture, lesdites interactions cellulaires pouvant être interrompues sous l'effet d'une action extérieure exercée sur le milieu de culture, sans que la majeure partie des cellules soient dégradées lorsqu'elles passent de l'état d'agglomérats à celui de cellules isolées. De préférence, l'expansion et/ou la modification des cellules intervien(nen)t à des conditions de culture bloquant au moins partiellement les récepteurs des cellules qui induisent l'établissement d'adhésions cellule-cellule. Le milieu de culture peut présenter une concentration en Ca?2+¿ inférieure ou égale à 0,5 mmol/l et/ou comporter des inhibiteurs spécifiques des récepteurs membranaires des cellules intervenant dans les interactions cellulaires.
Patent CA-2454797-A1 (CA)
Inventor: EDMOND JOHN
IPC: H01L33/62
Filed: 2002-07-22
Abstract: Light emitting device die having a mesa configuration on a substrate and an electrode on the mesa are attached to a submount in a flip-chip configuration by forming predefined pattern of conductive die attach material on at least one of the electrode and the submount and mounting the light emitting device die to the submount. The predefined pattern of conductive die attach material is selected so as to prevent the conductive die attach material from contacting regions of having opposite conductivity types when the light emitting device die is mounted to the submount. The predefined pattern of conductive die attach material may provide a volume of die attach material that is less than a volume defined by an area of the electrode and a distance between the electrode and the submount. Light emitting device dies having predefined patterns of conductive die attach material are also provided. Light emitting devices having a gallium nitride based light emitting region on a substrate, such as a silicon carbide substrate, may also be mounted in a flip-chip configuration by mounting an electrode of the gallium nitride based light emitting region to a submount utilizing a B-stage curable die epoxy. Light emitting device dies having a B-stage curable die epoxy are also provided.
Patent CA-2456293-A1 (CA)
Title: Process for the preparation of tolterodine
Inventor: KUMAR YATENDRA
IPC: C07C217/62
Filed: 2002-08-02
Abstract: The present invention relates to a cost effective and industrially advantageous process for the preparation of tolterodine and pharmaceutically acceptable salts thereof.
Patent CA-2456487-A1 (CA)
Inventor: MORTON-FINGER JUERGEN
IPC: D01D5/34
Filed: 2004-02-03
Abstract: A multi-layer monofilament consisting of multiple layers that are extruded simultaneously in a single process step, having a first layer made from plastic A, a second layer, which is bonded directly to the first layer, made from plastic B, and a third layer, which is bonded directly to the second layer, made from plastic C, plastic B being a bonding agent between the two plastics A and C.
Patent CA-2459267-A1 (CA)
Inventor: TAKANO MAKOTO
IPC: C12N15/29
Filed: 2002-08-30
Abstract: Rice phyC mutants were isolated using a mutant panel isolation method. When the mutants were grown under long-day photoperiodic conditions, it was found that they flowered (exposed their panicles (heads)) about one week earlier than the control rice. The results indicate that suppression of PHYC gene expression can promote plant flowering under long-day conditions. Utilization of the PHYC gene for promoting plant flowering will contribute substantially to breed improvement, for example, by facilitating the creation of useful agricultural crops and decorative plants that have a new characteristic adaptable for other cultivation areas and times. The rice phyC mutants described herein, which promote flowering under long-day conditions, will be highly prized as a new early-harvest rice cultivar.
Patent CA-2460095-A1 (CA)
Title: Procedes d'expression ciblee d'un acide nucleique therapeutique
Inventor: DRAKE RICHARD R
IPC: A61K35/76
Filed: 2002-06-13
Abstract: L'invention porte sur des vecteurs d'expression comprenant un acide nucléique présélectionné lié de manière fonctionnelle à une tumeur spécifique ou à un promoteur spécifique de type cellule et un activateur de transcription de la Tcf-4.beta.-caténine. L'acide nucléique thérapeutique comprend un gène codant une protéine thérapeutique utile dans le traitement du cancer, par exemple,. L'invention porte égalemtn sur des procédés d'expression ciblée de l'acide nucléique thérapeutique et sur des procédés de traitement du cancer utilisant les vecteurs d'expression précités. L'invention porte également sur des cellules hôtes qui ont été transformées par les vecteurs d'expression précités.
Patent CA-2463915-A1 (CA)
Inventor: BOMBARDELLI EZIO
IPC: C07D305/14
Filed: 2002-07-18
Abstract: A process for the preparation of 14.beta.-hydroxy-baccatin III-1,14-carbonate useful for the preparation of novel taxane derivatives with antitumor activity.
Patent CA-2464733-A1 (CA)
Title: Forming thin films on substrates using a porous carrier
Inventor: ARORA PRAMOD K
IPC: B05D3/02
Filed: 2002-10-24
Abstract: The invention relates to a composite containing a porous carrier (10) and an amphiphilic material. The composite may be employed in methods and systems for forming thin films on substrates.
Patent CA-2465682-A1 (CA)
Inventor: JOLIVET JACQUES
IPC: A61P35/02
Filed: 2002-11-04
Abstract: The present invention provides a novel method for treating leukemia in a host that has been previously treated with a BrcAbl tyrosine kinase inhibitor comprising administering to the host a therapeutically effective amount of a compound having the formula I: wherein B is cytosine or 5-fluorocytosine and R  is selected from H, monophosphate, diphosphate, triphosphate, carbonyl substituted with. a C1-5 alkyl, C1-5 alkenyl, C1-5 alkynyl, C5-10 aryl, and and wherein each. Rc is independently selected from the group comprising H, C1-5, alkyl, C1-5 alkenyl, C1-5.alkynyl an hydroxy protecting group
Patent CA-2471151-A1 (CA)
Inventor: YU KAI
IPC: A61K31/191
Filed: 2002-07-02
Abstract: The present invention relates to calcium L-threonate compound for preventing or treating cartilage related diseases, a pharmaceutical composition comprising the same and use of the same. It had been demonstrated by experiments that calcium L-threonate could improve significantly the positive expression percentage of collagen I mRNA in the chondrocyte and osteoblast, improved significantly the positive expression percentage of articular cartilage and epiphyseal cartilage, facilitated the growth of chondrocyte, increased the quantity of bone collagen, promoted the formation of bone and cartilage matrix and the synthesis of proteoglycan. It could also promote the formation of bone nourishing blood vessels and improve the microcirculation of bone.
Patent CA-2475151-A1 (CA)
Inventor: PATEL CHANDRAKANT D
IPC: F24F11/76
Filed: 2003-11-21
Abstract: L'invention concerne un système (220, 520) et un procédé (300, 600) permettant de refroidir une pièce (210) configurée pour contenir une pluralité de systèmes informatiques (212). Une pluralité d'unités d'évaporateurs (222, 522) sont agencés en parallèle et sont configurés pour recevoir de l'air provenant de la pièce et pour fournir de l'air à cette pièce. Des unités d'évaporateur sont fournies avec un fluide frigorigène permettant de refroidir l'air reçu dans les unités d'évaporateur. Cet air peut être commandé en réponse à des températures détectées à un ou à plusieurs emplacements de la pièce.
Patent CA-2475762-A1 (CA)
Title: Dose dependent elimination of ha and cell receptor stimulation
Inventor: TURLEY EVA A
IPC: A61K31/728
Filed: 2004-07-27
Abstract: The invention provides a method to alter elimination kinetics of hyaluronic acid (HA) in a patient is disclosed. Administration of HA to a patient, followed by at least one subsequent administration results in an alteration of the ability of the patient to eliminate HA. Also disclosed is a method for upregulating, and/or increasing the affinity of cellular HA receptors. Also disclosed are methods for increasing the ability of cells to bind HA improved imagine of cells and tissues, determination of the existence of disease in a patient.
Patent CA-2476268-A1 (CA)
Inventor: SHIMAMURA MICHIYA
IPC: A01N49/00
Filed: 2003-02-07
Abstract: La présente invention concerne un procédé de lutte contre les insectes nuisibles caractérisé en ce qu'un composé gazeux présentant une structure représentée par la formule (I) ( . indique une liaison simple ou une liaison double) est amené à être présent dans une concentration comprise entre 0,001 et 20,000µg/L dans un espace où on souhaite repousser les acariens ; et un agent de lutte contre les acariens contenant un composé représenté par la formule (I) en tant que principe actif.
Patent CA-2477145-A1 (CA)
Title: Rodless conveyor belt or chain
Inventor: JOHNSON MARK T
IPC: B65G17/06
Filed: 2003-02-26
Abstract: A modular link (10) or link section for use in forming a riddles conveyor belt or a section thereof is provided. In one embodiment, the link section is unitary and includes a plurality of laterally-repeating link-shaped portions (16), each including an apex portion (14) and a pair of leg portions (22, 24).  Each apex portion includes a receiver (18) for receiving an integral first connector (36) extending between the leg portions of a next-adjacent link or link section, preferably in snap-fit engagement, such that relative pivoting movement is established. A second integral connector (40) may be provided between the leg portion of each adjacent apex portion to create an engagement surface for a tooth of a drive or idler sprocket (s). The underside surface of each link section may also be specially contoured or curved to facilitate smooth passage over a guide structure (B), such as a small diameter, cylindrical nosebar or the like.
Patent CA-2478183-A1 (CA)
Title: Substituted amides
Inventor: HAGMANN WILLIAM K
IPC: C07D233/80
Filed: 2003-03-07
Abstract: Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment , prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in t he treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson s disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, th e treatment of obesity or eating disorders, as well as the treatment of asthma , constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.
Patent CA-2479672-A1 (CA)
Title: Preemptive prophylaxis of migraine
Inventor: CADY ROGER K
IPC: A61K31/70
Filed: 2003-03-14
Abstract: A method of preventing the headache phase of migraine in a human comprises administration of an anti-convulsant medication to said human exhibiting prodrome symptoms of migraine. Suitably, the method comprises administration of a migraine headache phase-preventing effective amount of the anti- convulsant. There is also disclosed a pharmaceutical composition for the prevention of the headache phase of a migraine containing an anti-convulsant as an active ingredient. There is also disclosed a method of determining prodromal symptoms of migraine using the following cognitive tests: Simple Reaction Time (103); Running Memory Continuous Performance Task (104); Matching to Sample (105); Mathematical Processing Task (106); and interpreti ng the results as a percent of baseline indicator of need for prophylaxis.</SDO AB>
Patent CA-2481170-A1 (CA)
Inventor: BURBANK FRED H
IPC: A61B17/12
Filed: 2003-04-04
Abstract: A compression and ligation device includes a pair of jaws including one or more Doppler chips oriented to send and receive Doppler signals across the jaws, to assist a practitioner in determining whether or not a uterine artery is between the jaws. A suture leader with an attached suture can be pushed through a channel on one of the jaws, through tissue behind the uterine artery, into another channel on the other jaw, and proximally out the device so that the practitioner can ligate the artery and effect hemostasis.
Patent CA-2481806-A1 (CA)
Inventor: MORISON ALAN B
IPC: B01D53/52
Filed: 2004-10-05
Abstract: A method of venting a liquid storage tank. A first step involves positioning a gas scrubber in the vicinity of a liquid storage tank. A second step involves extending a conduit from a vent of the liquid storage tack to an inlet of the gas scrubber. A  third step involves closing all other vents from the liquid storage tank, so that all gaseous phase emissions exiting the liquid storage tank must pass through the vent to which the conduit is connected. A fourth step involves creating a circulation to move gaseous phase emissions from the liquid storage tank through the gas scrubber.
Patent CA-2483353-A1 (CA)
Title: Conteneur pour le transport securitaire de cargaisons
Inventor: RELLE FERENC M JR
IPC: B61D45/00
Filed: 2004-09-30
Abstract: Séparateur temporaire et sécuritaire est prévu pour le cloisonnement d'un conteneur de marchandise, afin de le diviser en un compartiment protégé, et un compartiment non protégé, permettant le transport sécuritaire de cargaisons qui n'occupent pas un conteneur complet. L'invention prévoit également un conteneur pour de tels transports sécuritaires, ainsi que des méthodes et systèmes de transport sécuritaire d'une cargaison partielle.
Patent CA-2484178-A1 (CA)
Title: Citronella java oil containing composition and its use as insect repellent
Inventor: BENCSITS FRANZ
IPC: A01P7/00
Filed: 2003-04-15
Abstract: The invention relates to a composition containing a special essential oil, which can be used as an insect repellent.
Patent CA-2489523-A1 (CA)
Inventor: LORENCE ROBERT M
IPC: A61K35/76
Filed: 2003-05-22
Abstract: Selon cette invention, on administre au moins deux doses d'hyposensibilisation d'un virus thérapeutique, suivi d'une ou plusieurs doses augmentées du virus. Il est, de plus, possible de réguler la vitesse à laquelle le virus thérapeutique est administré.
Patent CA-2490799-A1 (CA)
Inventor: KEPPELER FRANK M
IPC: C22C9/06
Filed: 2003-07-01
Abstract: L'invention concerne un alliage de cuivre possédant une combinaison améliorée de limite élastique et de conductivité électrique, qui se compose essentiellement de 1 à 2,5 % en poids de nickel, de 0,5 à 2,0 % en poids de cobalt, avec une teneur totale en nickel et cobalt de 1,7 à 4,3 % en poids, de 0,5 à 1,5 % en poids de silicium avec un rapport (Ni+Co)/Si compris entre 3,5 et 6, le solde étant du cuivre et les impuretés inévitables, l'alliage de cuivre battu présentant une conductivité électrique de plus de 40 % I.A.C.S. Une amélioration supplémentaire de la combinaison de limite élastique et de conductivité électrique et de résistance accrue à la relaxation de contrainte est obtenue par une inclusion supplémentaire d'argent pouvant atteindre 1 % en poids. L'invention porte également sur la fabrication des alliages de l'invention ainsi que d'autres alliages cuivre-nickel-silicium, qui consiste en plusieurs étapes séquentielles, à savoir : a) la coulée de l'alliage de cuivre ; (b) la déformation à chaud (12) de l'alliage à base de cuivre coulé afin d'induire une première réduction de la section ; (c) la transformation en solution (14) de l'alliage à base de cuivre coulé à une température et pendant une durée efficaces pour qu'un alliage monophasé soit sensiblement obtenu ; (d) un premier recuit de vieillissement (18) de l'alliage à une température et pendant une durée efficaces pour qu'une quantité d'une seconde phase soit précipitée et qu'un alliage polyphasé contenant des siliciures soit formé ; (e) l'écrouissage (20) de l'alliage polyphasé pour l'obtention d'une seconde réduction de la section ; et (f) le second recuit de vieillissement (22) de l'alliage polyphasé à une température et pendant une durée efficaces pour induire la précipitation de siliciures additionnels et augmenter la conductivité, la température du second recuit de vieillissement étant inférieure à la température du premier recuit de vieillissement.
Patent CA-2490826-A1 (CA)
Inventor: BARBEAU DONALD L
IPC: A61K31/50
Filed: 2004-12-22
Abstract: The present invention relates to sable and highly purified stable hydralazine hydrochloride compositions and stable hydralazine-containing pharmaceutical compositions. A  sterile aqueous injectable pharmaceutical composition suitable for parenteral administration is described comprising a therapeutically effective dose of hydralazine hydrochloride in a pharmaceutically acceptable carrier or diluent wherein said hydralazine hydrochloride is essentially free of phthalazines, hydrazine and metel ions. In addition, a stable sterile aqueous pharmaceutical composition comprising hydralazine hydrochloride in a pharmaceutically acceptable salt or diluent is described that is colorless and has no visible particulate matter.
Patent CA-2491750-A1 (CA)
Title: Powder supply device and portable powder-deposition apparatus for ultra-fine powders
Inventor: TAPPHORN RALPH
IPC: B05B7/14
Filed: 2002-07-08
Abstract: The invention relates to a powder-fluidizing and feeding device (1) for use with coating and spray forming nozzles and guns. The device includes novel provisions for controlling and feeding powder (10) from a hopper (2) to a vibrating bowl (8), for heating and vibrating powders (10) in the hopper (2) to dissipate agglomeration and clumping of the powder (10), and for metering powders (10) from a vibrating bowl (8) to the spray nozzles and guns using a feedback control derived from powder mass loss rate measurements. The device is particularly useful for feeding ultra-fine and nanoscale particles
Patent CA-2497230-A1 (CA)
Title: A method for casting objects with an improved hub core assembly
Inventor: BLAND MICHAEL A
IPC: B22D18/04
Filed: 2005-02-16
Abstract: A method of casting an object, usually a railroad wheel, is provided. A graphite mold having a drag section and a cope section has an opening in the drag section allowing molten metal to be fed upwardly by pressure into the cast object cavity. A stopper pipe assembly extends through centrally located openings in the cope section and the drag section. The hub core seals against an opening in the drag section upon cessation of pouring to keep molten metal in the cavity in the mold. The hub core assembly is comprised of refractory material which the molten metal contacts thereby allowing the reuse of the hub core assembly.
Patent CA-2503776-A1 (CA)
Title: Scheduling in a high-performance computing (hpc) system
Inventor: RICHOUX ANTHONY N
IPC: G06F15/16
Filed: 2005-04-07
Abstract: In one embodiment, a method for scheduling in a high-performance computing (HPC) system includes receiving a call from a management engine that manages a cluster of nodes in the HPC system. The call specifies a request including a job for scheduling. The method further includes determining whether the request is spatial, compact, or nonspatial and noncompact. The method further includes,. if the request is spatial, generating one or more spatial combinations of nodes in the cluster and selecting one of the spatial combinations that is schedulable. The method further includes, if the request is compact, generating one or more compact combinations of nodes in the cluster and selecting one of the compact combinations that is schedulable. The method further includes, if the request is nonspatial and noncompact, identifying one or more schedulable nodes and generating a nonspatial and noncompact combination of nodes in the cluster.
Patent CA-2503939-A1 (CA)
Title: Trolley structure
Inventor: SU CHUNG-SHIU
IPC: B62B1/04
Filed: 2005-04-08
Abstract: A trolley structure allowing synchronous retraction or extension of a stand and two wheels includes a main frame, wheel bases, retainers, a stand, and a handlebar; each wheel base inserted onto a respective rod of the main frame and fixed with the respective retainer; the stand pivoted to the retainers; the handlebar inserted into retractable holders of the main frame; a plurality of troughs provided at the bottom of each wheel base; a driven gear pivoted to the outer edge of each retainer; a plurality of checking members provided on the driven gear to be held in the troughs for driving the driven gear to rotate; and an active gear provided on a first pivoting holder of the stand to mesh with the driven gear to drive the driven gear to turn.
Patent CA-2506242-A1 (CA)
Title: 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
Inventor: CHEN ZHENGMING
IPC: C07D401/04
Filed: 2003-11-17
Abstract: 4-Tetrazolyl-4-phenylpiperidine Compounds, compositions comprising an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound, methods for treating or preventing pain or diarrhea in an animal comprising administerin g to an animal in need thereof an effective amount of a 4-Tetrazolyl-4- phenylpiperidine Compound and methods for stimulating opioid-receptor functi on in a cell comprising contacting a cell capable of expressing an opioid receptor with an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound are disclosed.